Modeling T cell temporal response to cancer immunotherapy rationalize development of combinatorial treatments protocols
Single-cell RNA-seq · mouse · 1372 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 1372 samples
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocolsNature cancer · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE249630_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1049846 and SRA study SRP476542. Searching any of these in the dataset finder brings you back here.
The grouping that defines any comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Sample titles run AB10120 … AB13981 and carry no group information.
- GSM7952163 AB10120
- GSM7952164 AB10121
- GSM7952165 AB10122
- GSM7952166 AB10193
- GSM7952167 AB10194
- GSM7952168 AB10195
- GSM7952169 AB10196
- GSM7952170 AB10197
- GSM7952171 AB10198
- GSM7952172 AB10199
- GSM7952173 AB10200
- GSM7952174 AB10201
- GSM7952175 AB10202
- GSM7952176 AB10203
- GSM7952177 AB10204
- GSM7952178 AB10205
- GSM7952179 AB10206
- GSM7952180 AB10207
- GSM7952181 AB10208
- GSM7952182 AB10209
- GSM7952183 AB10210
- GSM7952184 AB10211
- GSM7952185 AB10212
- GSM7952186 AB10213
- GSM7952187 AB10214
- GSM7952188 AB10215
- GSM7952189 AB10216
- GSM7952190 AB10217
- GSM7952191 AB10218
- GSM7952192 AB10219
- GSM7952193 AB10220
- GSM7952194 AB10221
- GSM7952195 AB10222
- GSM7952196 AB10223
- GSM7952197 AB10224
- GSM7952198 AB10225
- GSM7952199 AB10226
- GSM7952200 AB10227
- GSM7952201 AB10228
- GSM7952202 AB10229
+ 1332 more — browse all 1372 samples with per-sample file links →
- GSE306986 Synergistic Stromal Remodeling and Dual Chemo-Immunotherapy in Pancreatic Cancer: A Two-Stage Losartan-Primed followed Nanocarrier Strategy for Tumor Microenvironment Reprogramming 24 samples shares immunotherapy, modeling
- GSE276771 A stem-loop RNA RIG-I agonist induces immunogenic death and vascular remodeling to potentiate cancer immunotherapy 10 samples shares immunotherapy, modeling
- GSE325822 Bimodal Imaging-Guided Temporal Optimization of Combined Chemotherapy and DC Vaccine Immunotherapy 45 samples shares immunotherapy, temporal
- GSE302715 A tumor-associated macrophage-targeted immunocytokine leveraging T and NK cell synergy for potent cancer immunotherapy [scRNA-seq] 187 samples shares immunotherapy
- GSE196790 Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk promoting immunosuppression and immunotherapy resistance 54 samples shares immunotherapy
- GSE311488 Chemotherapeutic Induction of Single-Stranded DNA Accumulation Sensitizes Triple-Negative Breast Cancer to Immunotherapy [scRNA-seq] 32 samples shares immunotherapy
- GSE281467 Coactivation of innate immune suppressive cells induces acquired resistance against cancer immunotherapy targeting the innate immune system [TIICs RNA-seq] 30 samples shares immunotherapy
- GSE338487 Antigen presentation requirements for effective cDC1-based cancer immunotherapy 27 samples shares immunotherapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.